Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Change in Accured Expenses (2016 - 2025)

INVO Fertility (IVF) has disclosed Change in Accured Expenses for 15 consecutive years, with -$65161.0 as the latest value for Q2 2025.

  • On a quarterly basis, Change in Accured Expenses rose 38.44% to -$65161.0 in Q2 2025 year-over-year; TTM through Sep 2025 was $432888.0, a 18.45% increase, with the full-year FY2024 number at $1.4 million, up 46.07% from a year prior.
  • Change in Accured Expenses was -$65161.0 for Q2 2025 at INVO Fertility, up from -$934839.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.4 million in Q4 2024 to a low of -$934839.0 in Q1 2025.
  • A 5-year average of $72101.7 and a median of $11776.5 in 2022 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: soared 2551.39% in 2023, then tumbled 3170.78% in 2025.
  • INVO Fertility's Change in Accured Expenses stood at $86336.0 in 2021, then tumbled by 169.92% to -$60363.0 in 2022, then soared by 841.64% to $447676.0 in 2023, then surged by 220.07% to $1.4 million in 2024, then crashed by 104.55% to -$65161.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Change in Accured Expenses are -$65161.0 (Q2 2025), -$934839.0 (Q1 2025), and $1.4 million (Q4 2024).